Literature DB >> 27256017

Porcine respiratory disease complex: Interaction of vaccination and porcine circovirus type 2, porcine reproductive and respiratory syndrome virus, and Mycoplasma hyopneumoniae.

Chanhee Chae1.   

Abstract

Porcine respiratory disease is a multifactorial and complex disease caused by a combination of infectious pathogens, environmental stressors, differences in production systems, and various management practices; hence the name porcine respiratory disease complex (PRDC) is used. Porcine circovirus type 2 (PCV2), porcine reproductive and respiratory syndrome virus (PRRSV), and Mycoplasma hyopneumoniae are considered to be the most important pathogens that cause PRDC. Although interactions among the three major respiratory pathogens are well documented, it is also necessary to understand the interaction between vaccines and the three major respiratory pathogens. PRRSV and M. hyopneumoniae are well known to potentiate PCV2-associated lesions; however, PRRSV and mycoplasmal vaccines can both enhance PCV2 viraemia regardless of the effects of the actual PRRSV or M. hyopneumoniae infection. On the other hand, M. hyopneumoniae potentiates the severity of pneumonia induced by PRRSV, and vaccination against M. hyopneumoniae alone is also able to decrease PRRSV viraemia and PRRSV-induced lung lesions in dually infected pigs. This review focuses on (1) interactions between PCV2, PRRSV, and M. hyopneumoniae; and (2) interactions between vaccines and the three major respiratory pathogens.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Mycoplasma hyopneumoniae; Porcine circovirus type 2; Porcine reproductive and respiratory syndrome virus; Porcine respiratory disease complex; Vaccine

Mesh:

Year:  2015        PMID: 27256017     DOI: 10.1016/j.tvjl.2015.10.030

Source DB:  PubMed          Journal:  Vet J        ISSN: 1090-0233            Impact factor:   2.688


  28 in total

1.  Porcine Circovirus Type 2 Suppresses IL-12p40 Induction via Capsid/gC1qR-Mediated MicroRNAs and Signalings.

Authors:  Qian Du; Xingchen Wu; Tongtong Wang; Xuefeng Yang; Zhenyu Wang; Yingying Niu; Xiaomin Zhao; Shan-Lu Liu; Dewen Tong; Yong Huang
Journal:  J Immunol       Date:  2018-06-01       Impact factor: 5.422

2.  Comparison of 3 vaccination strategies against porcine reproductive and respiratory syndrome virus, Mycoplasma hyopneumoniae, and porcine circovirus type 2 on a 3 pathogen challenge model.

Authors:  Jiwoon Jeong; Ikjae Kang; Seeun Kim; Kee Hwan Park; Changhoon Park; Chanhee Chae
Journal:  Can J Vet Res       Date:  2018-01       Impact factor: 1.310

Review 3.  NADC30-Like Porcine Reproductive and Respiratory Syndrome in China.

Authors:  Kegong Tian
Journal:  Open Virol J       Date:  2017-06-30

4.  Approaches for quantifying antimicrobial consumption per animal species based on national sales data: a Swiss example, 2006 to 2013.

Authors:  Luís P Carmo; Gertraud Schüpbach-Regula; Cedric Müntener; Anne Chevance; Gérard Moulin; Ioannis Magouras
Journal:  Euro Surveill       Date:  2017-02-09

5.  Field efficacy of Porcilis® PCV M Hyo versus a licensed commercially available vaccine and placebo in the prevention of PRDC in pigs on a French farm: a randomized controlled trial.

Authors:  Eric Pagot; Martial Rigaut; David Roudaut; Luca Panzavolta; Rika Jolie; Didier Duivon
Journal:  Porcine Health Manag       Date:  2017-02-01

6.  Porcine Alveolar Macrophage-like cells are pro-inflammatory Pulmonary Intravascular Macrophages that produce large titers of Porcine Reproductive and Respiratory Syndrome Virus.

Authors:  Elise Bordet; Pauline Maisonnasse; Patricia Renson; Edwige Bouguyon; Elisa Crisci; Mathieu Tiret; Delphyne Descamps; Cindy Bernelin-Cottet; Céline Urien; François Lefèvre; Luc Jouneau; Olivier Bourry; Jean-Jacques Leplat; Isabelle Schwartz-Cornil; Nicolas Bertho
Journal:  Sci Rep       Date:  2018-07-05       Impact factor: 4.379

7.  Mycoplasma hyopneumoniae resides intracellularly within porcine epithelial cells.

Authors:  B B A Raymond; L Turnbull; C Jenkins; R Madhkoor; I Schleicher; C C Uphoff; C B Whitchurch; M Rohde; S P Djordjevic
Journal:  Sci Rep       Date:  2018-12-06       Impact factor: 4.379

8.  Viral communities associated with porcine respiratory disease complex in intensive commercial farms in Sichuan province, China.

Authors:  Sinan Qin; Wenqiang Ruan; Hua Yue; Cheng Tang; Kelei Zhou; Bin Zhang
Journal:  Sci Rep       Date:  2018-09-06       Impact factor: 4.379

9.  Comparative Evaluation of Growth Performance between Bivalent and Trivalent Vaccines Containing Porcine Circovirus Type 2 (PCV2) and Mycoplasma hyopneumoniae in a Herd with Subclinical PCV2d Infection and Enzootic Pneumonia.

Authors:  Hyungmin Um; Siyeon Yang; Taehwan Oh; Keehwan Park; Hyejean Cho; Jeongmin Suh; Kyung-Duk Min; Chanhee Chae
Journal:  Vaccines (Basel)       Date:  2021-05-03

10.  A field efficacy and safety trial in the Netherlands in pigs vaccinated at 3 weeks of age with a ready-to-use porcine circovirus type 2 and Mycoplasma hyopneumoniae combined vaccine.

Authors:  Luuk Kaalberg; Victor Geurts; Rika Jolie
Journal:  Porcine Health Manag       Date:  2017-11-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.